ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 164 filers reported holding ARGENX SE in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,897,300 | +159.3% | 10,000 | +133.0% | 0.61% | +269.1% |
Q4 2021 | $1,503,000 | -46.2% | 4,291 | -53.6% | 0.16% | -29.8% |
Q3 2021 | $2,793,000 | +0.3% | 9,249 | 0.0% | 0.24% | +25.0% |
Q2 2021 | $2,785,000 | +9.3% | 9,249 | 0.0% | 0.19% | -3.6% |
Q1 2021 | $2,547,000 | -6.4% | 9,249 | 0.0% | 0.20% | -19.1% |
Q4 2020 | $2,720,000 | +0.9% | 9,249 | -9.9% | 0.24% | -9.1% |
Q3 2020 | $2,695,000 | +16.6% | 10,265 | 0.0% | 0.26% | +22.1% |
Q2 2020 | $2,312,000 | +71.0% | 10,265 | 0.0% | 0.22% | +28.4% |
Q1 2020 | $1,352,000 | -49.2% | 10,265 | -38.1% | 0.17% | -22.8% |
Q4 2019 | $2,662,000 | -39.5% | 16,581 | -57.0% | 0.22% | -67.7% |
Q3 2019 | $4,397,000 | -19.5% | 38,581 | 0.0% | 0.68% | -9.1% |
Q2 2019 | $5,462,000 | +30.3% | 38,581 | +14.9% | 0.75% | +95.0% |
Q1 2019 | $4,192,000 | -49.9% | 33,581 | -61.4% | 0.38% | -59.4% |
Q4 2018 | $8,366,000 | -19.1% | 87,081 | -36.1% | 0.94% | -20.6% |
Q3 2018 | $10,343,000 | – | 136,381 | – | 1.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |